chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"Moderna COVID-19 Vaccine EUA"  Body aches and fatigue for 12-15 hours starting about 18 hours after injection. Sore arm for 72 hours starting 3 hours after injection.
The Flu vaccine was the one administrated in the area that had the reaction. The day after the administration during the afternoon she had fever, she felt her legs with a type of numbness and the area was red. Thursday the area was hard and red, she visited the Dr. to his office and he administered SOLU-MEDROL and hydrocortisone cream. She came to the pharmacy on Friday to inform the event. Pharmacist called patient 09/30/2018 9:20 am and confirmed that she already recovered.
The evening of the 2nd shot my heart was racing.  It continued throughout the evening.  It seemed to calm down next morning.  Around day 4 or 5 after the vaccine I began to have random heart palpitations.  It would feel as though it would race, but it was more like it would skip a beat and then pick back up.  I would describe it as a flutter. It continued for about a month or so randomly.  It would keep me up at night sometimes.  I did report to my physician around a month after the shot.  At the time it was starting to resolve.  She recommended I wear a heart monitor for 48 hrs. Because of cost and the fact it seemed to resolve I have held off on getting the test.  I'm still considering followup.  I am concerned there may be damage to my heart and feel it was a direct result from the vaccine because of the timing compared to me not having this issue normally.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Mar2021 at 12:00 as dose 1, single (Batch/Lot number: unknown), in left arm, on 07Apr2021 at 12:00 as dose 2, single (Batch/Lot number: unknown), in left arm, on 21Oct2021 at 12:00 as dose 3 (booster), single (Batch/Lot number: unknown), in right arm and on 17May2022 at 11:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 61 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results; Negative; Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical information: The patient was not Pregnant.The patient has no other medication in 2weeks. The patient had no Known allergies. Paxlovid seemed to work initially - They have tested negative after 7 days of getting virus. On Day 10, felt just as bad as onset. On Day 11, tested positive. They were out of town when they believe they got infected. They tested positive when They got home.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Fever of 100.1, pain at site of injection, body aches at lower back/upper leg the morning after the shot.
Apporoximately 70 hours after vaccine administration, patient developed fever, joint pain and tightening of the throat that persisted for roughly 12 hours. No permanent injury occured due to the tightening of the throat. No treatment of the symptoms was performed by the patient. Patient subsequently had general malaise for 72 hours. Patient did not follow-up for evaluation or treatment during the symptoms and did not treat self for the symptoms. The symptoms resolved on their own.
high fever; muscle aches; chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache), PYREXIA (high fever), MYALGIA (muscle aches) and CHILLS (chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 39180) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 02-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced HEADACHE (Headache). On an unknown date, the patient experienced PYREXIA (high fever), MYALGIA (muscle aches) and CHILLS (chills). At the time of the report, HEADACHE (Headache), PYREXIA (high fever), MYALGIA (muscle aches) and CHILLS (chills) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.; Sender's Comments: Based on the current available information which includes a strong temporal association between the use of the product and the start date of the reported events, a causal relationship with the event cannot be excluded. The reported events are consistent with the known safety profile of the vaccine.
Pt recvd measles vax 21JUN91 & w/in 10 min & became diaphoretic, disoriented, & fainted;
Uncontrollable vomiting and diarrhea simultaneously; sweats, chills, shaking, headache beginning at 1:30AM Sunday, April 11 lasting until 4:00 PM Sunday evening
she had really bad pain in her arm to the point where she couldn't lift her arm; couldn't lift her arm; also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday; Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight; everything on the left side hurts; bad migraine; dizziness; nausea; Generalized soreness and pain on the left side of her body; muscle pain; This spontaneous case was reported by an other and describes the occurrence of PAIN IN EXTREMITY (she had really bad pain in her arm to the point where she couldn't lift her arm), MOBILITY DECREASED (couldn't lift her arm), RASH ERYTHEMATOUS (also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday), CHEST PAIN (Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight) and PAIN (everything on the left side hurts) in a female patient of an unknown age who received mRNA-1273 (batch no. 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 01-Apr-2021, the patient received dose of mRNA-1273 (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (she had really bad pain in her arm to the point where she couldn't lift her arm), MOBILITY DECREASED (couldn't lift her arm), RASH ERYTHEMATOUS (also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday), CHEST PAIN (Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight), PAIN (everything on the left side hurts), MIGRAINE (bad migraine), DIZZINESS (dizziness), NAUSEA (nausea), MYALGIA (Generalized soreness and pain on the left side of her body) and MYALGIA (muscle pain). At the time of the report, PAIN IN EXTREMITY (she had really bad pain in her arm to the point where she couldn't lift her arm), MOBILITY DECREASED (couldn't lift her arm), RASH ERYTHEMATOUS (also has a rash, raised and red, slowly spreading instead of getting smaller, surface area has been getting bigger since Thursday), CHEST PAIN (Left sided chest pain, sharp muscle pain in the chest, heart is really sharp and tight), PAIN (everything on the left side hurts), MIGRAINE (bad migraine), DIZZINESS (dizziness), NAUSEA (nausea), MYALGIA (Generalized soreness and pain on the left side of her body) and MYALGIA (muscle pain) had not resolved.        The action taken with mRNA-1273 (Unknown Route) was unknown.       No concomitant medication details were reported. No Treatment Medications were reported.    Reporter did not allow further contact
Beneficial side effect: warts disappeared,this was a very good side effect and it is a miracle for her; 18 warts in her 2 thumbs turned black; Arm a little sore; Patient had high blood pressure for a couple of days, but it went back to normal.; This spontaneous case was reported by a patient and describes the occurrence of SKIN DISCOLOURATION (18 warts in her 2 thumbs turned black), HYPERTENSION (Patient had high blood pressure for a couple of days, but it went back to normal.), PAIN IN EXTREMITY (Arm a little sore) and THERAPEUTIC RESPONSE UNEXPECTED (Beneficial side effect: warts disappeared,this was a very good side effect and it is a miracle for her) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 022M20A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (oesophageal), Blood pressure high (since she was 30 years old), Allergy to antibiotic (Cipro), Diabetes (since 3 years ago), Asthma (since she was 50 years old) and Warts. Concomitant products included ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for Acid reflux (oesophageal), LISINOPRIL for Blood pressure high, METFORMIN for Diabetes, INSULIN and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm a little sore). In 2021, the patient experienced HYPERTENSION (Patient had high blood pressure for a couple of days, but it went back to normal.). On 20-Sep-2021, the patient experienced SKIN DISCOLOURATION (18 warts in her 2 thumbs turned black). In October 2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Beneficial side effect: warts disappeared,this was a very good side effect and it is a miracle for her). On 02-Apr-2021, PAIN IN EXTREMITY (Arm a little sore) had resolved. In 2021, HYPERTENSION (Patient had high blood pressure for a couple of days, but it went back to normal.) had resolved. At the time of the report, SKIN DISCOLOURATION (18 warts in her 2 thumbs turned black) had resolved and THERAPEUTIC RESPONSE UNEXPECTED (Beneficial side effect: warts disappeared,this was a very good side effect and it is a miracle for her) outcome was unknown.            Patient received 1st booster on 10-Dec-2021 and batch/Lot number was reported as 060H21A  No treatment medication were provided.  After the vaccines where given, patient just had her arm a little sore, and after 1st and 2nd shot patient had high blood pressure for a couple of days, but it went back to normal. Patient considered that there was a beneficial AE after she received her 2nd dose: she stated that since like 5 years ago she had 18 warts in her 2 thumbs, and her HCP tried to freeze them, but it didn't work.  On 20-Sep-2021 patient noticed the warts turned black and after 1 or 2 weeks they disappeared.   This case was linked to MOD-2022-629199 (Patient Link).
Information has been received from a registered nurse concerning a 14 year old female patient with no pertinent medical history and no known drug allergies, who on 29-OCT-2008, was vaccinated with the first 0.5 ml dose of GARDASIL, IM, into her left arm (lot # 661764/0650X). Concomitant therapy included cetirizine hydrochloride (ZYRTEC). On 29-OCT-2008, the patient experienced severe joint and muscle pain. No lab diagnostics studies were performed. The patient sought unspecified medical attention, and the physician advised patient to take ibuprofen and to continue taking her cetirizine hydrochloride (ZYRTEC). At the time of reporting, the adverse events were ongoing. Additional information has been requested.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site induration in a 68-year-old female patient who received SHINGRIX (batch number ZY3X4, expiry date 28th April 2020). On 22nd May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In May 2018, less than a week after receiving SHINGRIX, the patient experienced injection site induration, injection site erythema, injection site itching and injection site pain. On 22nd May 2018, the patient experienced fever, general body pain and headache. On an unknown date, the outcome of the injection site induration, injection site erythema, injection site itching and injection site pain. On 22nd May 2018, the patient experienced fever, general body pain and headache. On an unknown date, the outcome of the injection site induration, injection site erythema, injection site itching and injection site pain were not recovered/not resolved and the outcome of the fever, general body pain and headache were recovering/resolving. The reporter considered the injection site induration, injection site erythema, injection site itching, injection site pain, fever, general body pain and headache to be probably related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX in the right arm. The HCP was a retail pharmacist. The healthcare professional (HCP) stated that patient developed a headache, fever, and body soreness within 24 hours of receiving the SHINGRIX vaccine. Since then those symptoms were resolving at the time of reporting. The patient had also developed a hard, red, itchy, painful area that was 3 inches in diameter on the patients right arm 2 and 1/2 inches below the injection site. The HCP stated that the patient not had any interventions or sought any medical treatment other than to call the pharmacy. The HCP recommended the patient that call her MD, but patient declined.
SORE AND ACHING JOINTS WITH FLU LIKE SYMPTOMS APPROX 1 1/2 DAYS AFTER SHOT. ON SECOND DAY AFTER SHOT STIFF NECK WITH PAIN ON BOTH SIDES. FLU SYMPTOMS LAST FOR 2 WEEKS AND NECK PROBLEM CONTINUES UNTIL 3 DAYS BEFORE NEXT SHOT BEING 4/25. NECK PAIN BECOMING UNBEARABLE . NOTHING I TAKE WILL HELP. FELT GOOD FOR 3 DAYS.
Injected the 0.1 dose of vaccine to the site but upon removal of needle, a  large amount of the vaccine leaked out of the wheal and the wheal flattened immediately, leaving a flattened blanched area in the skin. Due to not knowing how much of the dose actually remained inside the wheal area, the vaccine was re-administered using the Subcutaneous method in the posterior Left upper arm. Patient reported no pain at the initial intradermal injection site.
This spontaneous case was reported by a patient family member or friend and describes the occurrence of PRODUCT ADMINISTRATION INTERRUPTED (tated her son and his girlfriend received a single dose of the vaccine last year, but never received a second dose) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTRATION INTERRUPTED (tated her son and his girlfriend received a single dose of the vaccine last year, but never received a second dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT ADMINISTRATION INTERRUPTED (tated her son and his girlfriend received a single dose of the vaccine last year, but never received a second dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided          No Concomitant medication was reported. No treatment information was provided.
given all 6 doses of a undiluted vial; Overdose; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 16Mar2021 at 10:00 (at the age of 57-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had not received any other vaccines within 4 weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Mar2021 at 10:00, the patient was given all six doses of an undiluted vial also asked whether he should still go for the second shot. The patient did not receive treatment for the reported events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event given all six doses of an undiluted vial was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 2008, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and on an unknown date the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. The patient was treated at a hospital for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for the long-term prevention of shingles, the patient suffered injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Itching and large rash around the injection area (right arm) that is hot when touched.
Received vaccine at 2:15pm on Friday 3/5/21.  At 7:15pm on Friday 3/5/21, began feeling slight throat tightness then Tingling sensation in Lips, Numb Nose, Rapid and Heavy Pounding Heartbeat, Tingling in front half of Tongue.  Went outside to take breaths of cool air twice and then took 2 Bayer aspirin.  Event lasted for about 30 minutes.  After the issues passed, continued to have slight tingling in tongue and metallic taste in mouth until Tuesday morning 3/10/21.
breakthrough case Covid + 9.7.2021, symptoms, SOB, cough, weakness, CXR: clear
Pain, which initiated within few days after vaccination and still present a few weeks out after vaccine was administered. (Pain soreness on arm which vaccine was given).
Diarrhea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6202), via unspecified route of administration in the arm left on 26Mar2021 at 11:15 (at the age of 47-years-old), as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy. The patient did not take any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8727), via unspecified route of administration in the left arm on 04Mar2021 at 10:00 (at the age of 46-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 27Mar2021 at 03:00, the patient experienced diarrhea and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the events. The clinical outcome of the events diarrhea and fatigue was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected
Information has been received from a medical assistant referring to a currently 62 year old female patient with diverticulitis and pleurisy. The patient had no drug reactions/allergies. Her medical history included pulmonary embolism (3 episodes). In approximately 2009 (reported as "approximately seven years ago"), the patient was vaccinated with an unspecified pneumococcal vaccine (lot #, expiration date, dose and route were not reported) for prophylaxis. It was not known if the PNEUMOVAX23. On an unknown date, the patient experienced aggravation of her asthma. No treatment was given for the event. The medical assistant reported there was no current issues with the patient. The causality was not reported. Additional information has been requested.
Change in taste and smell. My sense of smell has decreased significantly to where I cannot smell things that I would have normally sensed before getting the vaccine. Also, some things that used to smell good, such as soap, now smell awful to me.   My sense of taste has also significantly changed. Some things taste terrible to me, that before the vaccine, tasted good to me. Some meat now tastes bad, specifically steak and turkey. Whereas before the shot I never had any problems with my sense of taste with meat.  After receiving the shots, I lost both taste and smell, and it slowly returned. However, now that it has returned, I now have the issues listed above.   It?s tolerable, but not enjoyable by any means, I just wanted to report this in the event that others have been having the same issues, with the hopes that there is some way to fix it.
patient got so sick; Initial information was received on 17-Nov-2020 regarding an unsolicited valid non-serious case from a social media via consumer or non-health care professional (patient).  This case involves patient [age and gender unspecified] who got so sick, while patient received vaccine INFLUENZA VACCINE [Flu shot].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number and expiry date not reported] via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient got so sick (illness) unknown latency following the administration of INFLUENZA VACCINE.  Details of laboratory data not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the event outcome reported as unknown for event.  There will be no information available on the batch number for this case.
Mom states within one hour of Hep B vaccine, child developed small blisters and hives with itching on shoulder and arm Hep B given in that spread all over body. Denies fever, SOB or swelling in and around face and neck. States pain and muscular difficulties with both hands.
Vomiting, Nausea, high fever 102-103, Tingling in legs, severe malaise and fatigue, severe headache. Unable to work, dizziness.
Co-worker reported a "sever headache" and later at 2:05pm  she reported she was "unable to open her right eye due to the severe pain in her head". She took Benadryl 25mg by mouth. Her mother came and picked her up  to take her home after an hour without any additional symptoms. The co-worker reported she still had a "headache" the next day, but it was much better.